# Tuya Inc.: financial statements, quarterly

TUYA · NYSE · CIK 1829118 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tuya.md) · [Financials](/companies/tuya/financials.md) · [Filings](/companies/tuya/filings.md) · [Insiders](/companies/tuya/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tuya/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | period not labelled (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [213](/filings/0001104659-22-052200.md) | [159](/filings/0001104659-23-049845.md) | [964](/filings/0001104659-24-050855.md) | [133](/filings/0001410578-25-000850.md) | [499](/filings/0001104659-26-046399.md) | [653](/filings/0001104659-26-046399.md) | [891](/filings/0001104659-26-046399.md) |
| Current assets | $m | not reported | not reported | [248](/filings/0001104659-22-052200.md) | [1,191](/filings/0001104659-23-049845.md) | [1,023](/filings/0001104659-24-050855.md) | [848](/filings/0001410578-25-000850.md) | [903](/filings/0001104659-26-046399.md) | [1,023](/filings/0001104659-26-046399.md) |
| Total assets | $m | not reported | not reported | [267](/filings/0001104659-22-052200.md) | [1,248](/filings/0001104659-23-049845.md) | [1,056](/filings/0001104659-24-050855.md) | [1,066](/filings/0001410578-25-000850.md) | [1,104](/filings/0001104659-26-046399.md) | [1,133](/filings/0001104659-26-046399.md) |
| Current liabilities | $m | not reported | not reported | [91.9](/filings/0001104659-22-052200.md) | [109](/filings/0001104659-23-049845.md) | [81.3](/filings/0001104659-24-050855.md) | [87.5](/filings/0001410578-25-000850.md) | [94.3](/filings/0001104659-26-046399.md) | [106](/filings/0001104659-26-046399.md) |
| Total liabilities | $m | not reported | not reported | [98.3](/filings/0001104659-22-052200.md) | [134](/filings/0001104659-23-049845.md) | [94.0](/filings/0001104659-24-050855.md) | [95.8](/filings/0001410578-25-000850.md) | [96.3](/filings/0001104659-26-046399.md) | [110](/filings/0001104659-26-046399.md) |
| Shareholders' equity | $m | [(41.0)](/filings/0001104659-22-052200.md) | [(110)](/filings/0001104659-23-049845.md) | [(165)](/filings/0001104659-24-050855.md) | [1,114](/filings/0001410578-25-000850.md) | [962](/filings/0001104659-26-046399.md) | [971](/filings/0001104659-26-046399.md) | [1,007](/filings/0001104659-26-046399.md) | [1,023](/filings/0001104659-26-046399.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 611,528,176 at 2025-12-31, from the cover of the [20-F filed 2026-04-22](/filings/0001104659-26-046399.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.